Outcome of AGM of Vista Pharmaceutical Limited held on 30.09.2025

Vista Pharmaceuticals held its 34th AGM on September 30, 2025, via video conferencing from 11:00 AM to 11:26 AM. All 8 resolutions were passed with a strong majority of approximately 98.74% in favour and only 1.26% against. The resolutions covered adoption of FY25 (ended March 31, 2025) audited financial statements, re-appointment of two retiring directors (Mr. Divakar Reddy Yerrabommanahalli and Mr. Umakanth Katta), re-appointment of statutory auditors, appointment of M/s. Aakanksha Dubey & Co. as secretarial auditors for five years, and re-appointment of three executive directors — Mr. Murali Meraga as Managing Director, Mr. Pavan Sathvik Gilaka as Whole-time Director, and Dr. Dhananjaya Alli as Whole-time Director. Of the 14,061 shareholders on record date, 72 attended through VC and about 15.53% of outstanding shares were polled. The Chairman noted that members expressed appreciation for the company's performance, and the scrutinizer certified all resolutions as duly passed.